Bicycle Therapeutics (BCYC) Exchange Rate Effect (2018 - 2026)
Bicycle Therapeutics (BCYC) posted Exchange Rate Effect of -$1.9 million for Q1 2026, down 775.68% on a QoQ basis from -$222000.0 in Q4 2025, and down 515.38% year-over-year from $468000.0 in Q1 2025.
Bicycle Therapeutics (BCYC) Exchange Rate Effect (2018 - 2026) Analysis & Trends
Bicycle Therapeutics' Exchange Rate Effect history runs 9 years deep, the most recent figure standing at -$1.9 million for Q1 2026.
- Quarterly Exchange Rate Effect fell 515.38% year-over-year to -$1.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.6 million (down 946.32% YoY) and the FY2025 annual result came in at $804000.0, up 215.85% from the prior year.
- Exchange Rate Effect was -$1.9 million for Q1 2026 at Bicycle Therapeutics, down from -$222000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $3.6 million in Q4 2022 and bottomed at -$2.6 million in Q3 2022.
- A 5-year average of -$94588.2 and a median of -$222000.0 in 2025 frame the typical range for Exchange Rate Effect.
- Peak annual rise in Exchange Rate Effect reached 59333.33% in 2022, while the deepest fall reached 743.1% in 2022.
- Bicycle Therapeutics' Exchange Rate Effect stood at $3.6 million in 2022, then slumped by 63.73% to $1.3 million in 2023, then slumped by 238.17% to -$1.8 million in 2024, then jumped by 87.54% to -$222000.0 in 2025, then sank by 775.68% to -$1.9 million in 2026.
- Business Quant data shows BCYC's Exchange Rate Effect at -$1.9 million in Q1 2026, -$222000.0 in Q4 2025, and -$1.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 19.32 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 14,631.83 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Bicycle Therapeutics | 289.88 Mn | 289.88 Mn | - | -1.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.94 Mn |
| Mar 31, 2026 | -1.94 Mn |
| Dec 31, 2025 | -222,000.00 |
| Dec 31, 2025 | -222,000.00 |
| Sep 30, 2025 | -1.25 Mn |
| Sep 30, 2025 | -1.25 Mn |
| Jun 30, 2025 | 1.81 Mn |
| Jun 30, 2025 | 1.81 Mn |
| Mar 31, 2025 | 468,000.00 |
| Mar 31, 2025 | 468,000.00 |
| Dec 31, 2024 | -1.78 Mn |
| Dec 31, 2024 | -1.78 Mn |
| Sep 30, 2024 | 1.70 Mn |
| Sep 30, 2024 | 1.70 Mn |
| Jun 30, 2024 | -192,000.00 |
| Jun 30, 2024 | -192,000.00 |
| Mar 31, 2024 | -416,000.00 |
| Mar 31, 2024 | -416,000.00 |
| Dec 31, 2023 | 1.29 Mn |
| Dec 31, 2023 | 1.29 Mn |